Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05210114 · ClinicalTrials.gov registry record · NA

Cutaneous Hydration Assessment in SCD

A NA study of Sickle Cell Disease, sponsored by Enrico Novelli.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05210114 is a NA study of Sickle Cell Disease that is actively recruiting participants, run by Enrico Novelli. The registered enrollment target is 30 participants, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05210114, a NA study of Sickle Cell Disease, is actively recruiting participants, sponsored by Enrico Novelli.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

Conditions Studied

Interventions

  • DEVICE Skin Hydration Sensor

Study Locations (1)

Pennsylvania

  • UPMC Sickle Cell Clinic - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-01-21
Est. Completion 2027-12-31
Phase NA

Sponsor

Enrico Novelli

2 total trials

What the Registry Record Tells You About NCT05210114

The ClinicalTrials.gov registry entry for NCT05210114 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (90% lower). The listed sponsor is Enrico Novelli, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sickle Cell Disease appearing as the primary indexed condition, and to 1 intervention - of which Skin Hydration Sensor is the first listed.

NCT05210114 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05210114 about?

NCT05210114 is a clinical study titled "Cutaneous Hydration Assessment in SCD". This study will validate the diagnostic accuracy of a cutaneous hydration sensor. This sensor will also be evaluated for its feasibility as a point-of-care device for the assessment of hydration status and its potential to guide hydration therapy in patients with sickle cell disease (SCD).

What is the current status of trial NCT05210114?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-01-21. Estimated completion is 2027-12-31.

What conditions does trial NCT05210114 study?

This clinical trial studies the following conditions: Sickle Cell Disease.

What interventions are being tested in trial NCT05210114?

The interventions under investigation include: Skin Hydration Sensor (DEVICE).

Who is sponsoring clinical trial NCT05210114?

This trial is sponsored by Enrico Novelli, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05210114 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sickle Cell Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.